United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
284.27
+0.18 (0.06%)
At close: Jun 27, 2025, 4:00 PM
284.12
-0.15 (-0.05%)
After-hours: Jun 27, 2025, 5:34 PM EDT
United Therapeutics Employees
United Therapeutics had 1,305 employees as of December 31, 2024. The number of employees increased by 137 or 11.73% compared to the previous year.
Employees
1,305
Change (1Y)
137
Growth (1Y)
11.73%
Revenue / Employee
$230,315,385
Profits / Employee
$93,130,769
Market Cap
12.82B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,305 | 137 | 11.73% |
Dec 31, 2023 | 1,168 | 183 | 18.58% |
Dec 31, 2022 | 985 | 20 | 2.07% |
Dec 31, 2021 | 965 | 15 | 1.58% |
Dec 31, 2020 | 950 | 30 | 3.26% |
Dec 31, 2019 | 920 | 60 | 6.98% |
Dec 31, 2018 | 860 | 60 | 7.50% |
Dec 31, 2017 | 800 | 50 | 6.67% |
Dec 31, 2016 | 750 | 0 | - |
Dec 31, 2015 | 750 | 10 | 1.35% |
Dec 31, 2014 | 740 | 34 | 4.82% |
Dec 31, 2013 | 706 | 83 | 13.32% |
Dec 31, 2012 | 623 | 80 | 14.73% |
Dec 31, 2011 | 543 | 23 | 4.42% |
Dec 31, 2010 | 520 | 110 | 26.83% |
Dec 31, 2009 | 410 | 50 | 13.89% |
Dec 31, 2008 | 360 | 40 | 12.50% |
Dec 31, 2007 | 320 | 35 | 12.28% |
Dec 31, 2006 | 285 | 75 | 35.71% |
Dec 31, 2005 | 210 | 40 | 23.53% |
Dec 31, 2004 | 170 | 10 | 6.25% |
Dec 31, 2003 | 160 | 10 | 6.67% |
Dec 31, 2002 | 150 | 22 | 17.19% |
Dec 31, 2001 | 128 | 18 | 16.36% |
Dec 31, 2000 | 110 | 47 | 74.60% |
Dec 31, 1999 | 63 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
UTHR News
- 4 days ago - United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver - Business Wire
- 5 days ago - United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension - Business Wire
- 16 days ago - United Therapeutics: Tanking On Rival's PAH Data - I'd Consider Buying Stock - Seeking Alpha
- 2 months ago - United Therapeutics Corporation (UTHR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - United Therapeutics Corporation Reports First Quarter 2025 Financial Results - Business Wire
- 2 months ago - United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference - Business Wire
- 3 months ago - United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions - Business Wire
- 3 months ago - United Therapeutics: Don't Fear The Patent Expiration Too Much - Seeking Alpha